Anti-ribosomal p protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice

Arthritis and Rheumatology

Volumn 67, Issue 1, 2015, Pages 204-214

  Bravo Zehnder, Marcela ^a   Toledo, Enrique M ^a   Segovia Miranda, Fabián ^a   Serrano, Felipe G ^a   Benito, María J ^a   Metz, Claudia ^a   Retamal, Claudio ^a   Álvarez, Alejandra ^a   Massardo, Loreto ^a   Inestrosa, Nibaldo C ^a   González, Alfonso ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; CASPASE 3; LIPOPOLYSACCHARIDE; MEMBRANE ANTIGEN; NEURONAL SURFACE P ANTIGEN; RIBOSOMAL P PROTEIN AUTOANTIBODY; UNCLASSIFIED DRUG; RIBOSOME PROTEIN;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN DYSFUNCTION; CALCIUM CELL LEVEL; CELL SURFACE; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE IMMUNOFLUORESCENCE; EMBRYO; ENZYME ACTIVATION; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAZE TEST; MEMORY; MOUSE; NERVE CELL; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NICK END LABELING; NONHUMAN; PRIMARY CULTURE; STAINING; STEREOTAXIS; SYSTEMIC LUPUS ERYTHEMATOSUS; WATER MAZE TEST; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BRAIN VASCULITIS; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; MEMORY DISORDERS; METABOLISM; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ANIMALS; ANTIGENS, SURFACE; APOPTOSIS; AUTOANTIBODIES; BLOOD-BRAIN BARRIER; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MEMORY DISORDERS; MICE; MICE, INBRED BALB C; NEURONS; RIBOSOMAL PROTEINS; YOUNG ADULT;

EID: 84919918139     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38900     Document Type: Article

References (45)

1. Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA, Sanna G,. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. J Neurol 2014; 261: 1706-14.
2. Hanly JG,. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol 2014; 10: 338-47.
3. Eber T, Chapman J, Shoenfeld Y,. Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality? Lupus 2005; 14: 571-5.
4. Rekvig OP, Putterman C, Casu C, Gao HX, Ghirardello A, Mortensen ES, et al. Autoantibodies in lupus: culprits or passive bystanders? Autoimmun Rev 2012; 11: 596-603.
5. Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT,. Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol 2009; 9: 449-56.
6. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317: 265-71.
7. Massardo L, Burgos P, Martinez ME, Perez R, Calvo M, Barros J, et al. Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease. Lupus 2002; 11: 379-83.
8. Karassa FB, Afeltra A, Ambrozic A, Chang DM, De Keyser F, Doria A, et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006; 54: 312-24.
9. Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S, et al. Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 2009; 32: 79-84.
10. Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Clarke A, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis 2011; 70: 1726-32.
11. Hirohata S, Arinuma Y, Takayama M, Yoshio T,. Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther 2007; 9: R44.
12. Katzav A, Solodeev I, Brodsky O, Chapman J, Pick CG, Blank M, et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007; 56: 938-48.
13. Katzav A, Ben-Ziv T, Chapman J, Blank M, Reichlin M, Shoenfeld Y,. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J Autoimmun 2008; 31: 393-8.
14. Matus S, Burgos PV, Bravo-Zehnder M, Kraft R, Porras OH, Farias P, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med 2007; 204: 3221-34.
15. Elkon K, Skelly S, Parnassa A, Moller W, Danho W, Weissbach H, et al. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci U S A 1986; 83: 7419-23.
16. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, et al. Cognition and immunity: antibody impairs memory. Immunity 2004; 21: 179-88.
17. Fanselow MS, Dong HW,. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 2010; 65: 7-19.
18. Bertsias GK, Boumpas DT,. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol 2010; 6: 358-67.
19. Kozora E, Hanly JG, Lapteva L, Filley CM,. Cognitive dysfunction in systemic lupus erythematosus: past, present, and future [review]. Arthritis Rheum 2008; 58: 3286-98.
20. Gladman DD, Ibanez D, Urowitz MB,. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002; 29: 288-91.
21. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
22. Levaux MN, Potvin S, Sepehry AA, Sablier J, Mendrek A, Stip E,. Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. Eur Psychiatry 2007; 22: 104-15.
23. Calderon J, Flores P, Babul M, Aguirre J, Slachevsky A, Padilla O, et al. Systemic lupus erythematosus impairs memory cognitive tests not affected by depression. Lupus 2014; 23: 1042-53.
24. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M. I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 Suppl 20: 22-33.
25. Farias GG, Alfaro IE, Cerpa W, Grabowski CP, Godoy JA, Bonansco C, et al. Wnt-5a/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons. J Biol Chem 2009; 284: 15857-66.
26. Varela-Nallar L, Alfaro IE, Serrano FG, Parodi J, Inestrosa NC,. Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proc Natl Acad Sci U S A 2010; 107: 21164-9.
27. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
28. Cancino J, Torrealba C, Soza A, Yuseff MI, Gravotta D, Henklein P, et al. Antibody to AP1B adaptor blocks biosynthetic and recycling routes of basolateral proteins at recycling endosomes. Mol Biol Cell 2007; 18: 4872-84.
29. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36.
30. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006; 103: 19854-9.
31. Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000; 408: 975-9.
32. Toledo EM, Inestrosa NC,. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease. Mol Psychiatry 2010; 15: 272-85.
33. Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N,. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc Natl Acad Sci U S A 1988; 85: 5186-9.
34. Hasler P, Brot N, Weissbach H, Danho W, Blount Y, Zhou JL, et al. The effect of phosphorylation and site-specific mutations in the immunodominant epitope of the human ribosomal P proteins. Clin Immunol Immunopathol 1994; 72: 273-9.
35. Mahler M, Kessenbrock K, Raats J, Williams R, Fritzler MJ, Bluthner M,. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins. J Mol Med 2003; 81: 194-204.
36. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B,. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 2006; 103: 678-83.
37. Orrenius S, Zhivotovsky B, Nicotera P,. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552-65.
38. Koren E, Reichlin MW, Koscec M, Fugate RD, Reichlin M,. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992; 89: 1236-41.
39. Koscec M, Koren E, Wolfson-Reichlin M, Fugate RD, Trieu E, Targoff IN, et al. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J Immunol 1997; 159: 2033-41.
40. Faust TW, Chang EH, Kowal C, Berlin R, Gazaryan IG, Bertini E, et al. Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci U S A 2010; 107: 18569-74.
41. Vincent A, Bien CG, Irani SR, Waters P,. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011; 10: 759-72.
42. Graus F, Saiz A, Dalmau J,. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010; 257: 509-17.
43. Abbott NJ, Mendonca LL, Dolman DE,. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003; 12: 908-15.
44. Hanly JG, Walsh NM, Fisk JD, Eastwood B, Hong C, Sherwood G, et al. Cognitive impairment and autoantibodies in systemic lupus erythematosus. Br J Rheumatol 1993; 32: 291-6.
45. McLaurin EY, Holliday SL, Williams P, Brey RL,. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64: 297-303.